mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |